Here are the 11 healthcare company CEOs that made the list, followed by their total compensation, change in pay year over year and the CEO-to-worker pay ratio.
David Ricks. CEO of Eli Lilly and Company
Total compensation: $25,125,910
Change in pay: 17%
CEO-to-worker pay ratio:168
Richard Gonzalez. CEO of AbbVie
Total compensation:$24,330,355
Change in pay: -6%
CEO-to-worker pay ratio: 169
Daniel O’Day. CEO of Gilead Sciences
Total compensation: $22,607,690
Change in pay: 5%
CEO-to-worker pay ratio: 110
Joaquin Duato. CEO of Johnson & Johnson
Total compensation: $21,936,740
Change in pay: 67%
CEO-to-worker pay ratio: 338
Gail Boudreaux. CEO of Elevance Health
Total compensation: $21,889,039
Change in pay: 5%
CEO-to-worker pay ratio: 389
Albert Bourla, PhD. CEO of Pfizer
Total compensation: $21,553,624
Change in pay: -29%
CEO-to-worker pay ratio: 291
Joseph Zubretsky. CEO of Molina Healthcare
Total compensation: $21,491,723
Change in pay: -3%
CEO-to-worker pay ratio: 273
Samuel Hazen. CEO of HCA Healthcare
Total compensation: $21,315,984
Change in pay: 46%
CEO-to-worker pay ratio: 356
David Cordani. CEO of The Cigna Group
Total compensation: $20,966,670
Change in pay: 0%
CEO-to-worker pay ratio: 280
Kevin Lobo. CEO of Stryker Corporation
Total compensation: $20,767,847
Change in pay: 12%
CEO-to-worker pay ratio: 247
Robert Ford. CEO of Abbott Laboratories
Total compensation: $19,602,891
Change in pay: -9%
CEO-to-worker pay ratio: 176
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
